360 NEWS360 NEWS

Business ยท National

USFDA issues 7 observations to NATCO Pharma's Hyderabad facility

NATCO Pharma says the observations are believed to be procedural in nature and is confident of addressing them in time

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on โ€œUSFDA issues 7 observations to NATCO Pharma's Hyderabad facilityโ€?

This is self-selected reader participation, not representative scientific polling.